Figure 5From: Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomesCell survival rates of HER2-positive SKBR3 (A) and HER2-negative HeLa (B) cells treated by siRNA combined with RNAiMAX (white bars), LPs (gray bars) and Z HER2 -BNC/LP complex (black bars). The fluorescence of cells stained with EthD-1 was analyzed using a flow cytometer. Cell survival rates were calculated by subtracting the dead cell counts from the total cell counts.Back to article page